Published in J Neurosurg on November 01, 2009
Regulation of enhanced cerebrovascular expression of proinflammatory mediators in experimental subarachnoid hemorrhage via the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway. J Neuroinflammation (2012) 0.89
Free Fatty acids and delayed cerebral ischemia after subarachnoid hemorrhage. Stroke (2012) 0.81
Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery (1980) 5.59
Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg (2004) 2.59
Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. JAMA (2005) 2.47
In vivo animal models of cerebral vasospasm: a review. Neurosurgery (2000) 1.94
Time course of vasospasm in man. J Neurosurg (1978) 1.93
Intracisternal sodium nitroprusside fails to prevent vasospasm in nonhuman primates. Neurosurgery (2002) 1.42
Studies of cerebrospinal fluid flow and penetration into brain following lateral ventricle and cisterna magna injections of the tracer [14C]inulin in rat. Neuroscience (2000) 1.25
A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery (1995) 1.08
Effects of intracranial dopamine perfusion: behavioural arousal and reversal of cerebral arterial spasm following surgery for clipping of ruptured cerebral aneurysms. Proc R Soc Med (1977) 1.08
Blood clot resolution in human cerebrospinal fluid: evidence of first-order kinetics. Neurosurgery (2001) 0.95
Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections. Anesthesiology (2004) 0.91
A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 1: Clinical and radiological findings. J Neurosurg (1984) 0.90
Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis. Neurosurgery (2004) 0.89
Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans. Neurosurgery (1999) 0.89
Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: pilot study of treatment with intraventricular tissue plasminogen activator. Neurosurgery (2005) 0.88
Effect of intraventricular sodium nitroprusside on cerebral hemodynamics and oxygenation in poor-grade aneurysm patients with severe, medically refractory vasospasm. Neurosurgery (2002) 0.87
Microcatheter intrathecal urokinase infusion into cisterna magna for prevention of cerebral vasospasm: preliminary report. Stroke (2000) 0.87
Endothelin and subarachnoid hemorrhage-induced cerebral vasospasm: pathogenesis and treatment. Curr Med Chem (2004) 0.86
Intrathecal medication delivery. Neurosurg Clin N Am (2003) 0.86
A comparison of 3 radiographic scales for the prediction of delayed ischemia and prognosis following subarachnoid hemorrhage. J Neurosurg (2008) 0.84
Comparison of intrathecal administration of urokinase and tissue plasminogen activator on subarachnoid clot and chronic vasospasm in a primate model. Neurosurgery (1993) 0.83
Evaluation of the efficacy of intrathecal nimodipine in canine models of chronic cerebral vasospasm. J Neurosurg (1985) 0.83
Effects of a nitric oxide donor on and correlation of changes in cyclic nucleotide levels with experimental vasospasm. Neurosurgery (2003) 0.82
Experimental evaluation of the beneficial effect of an antioxidant on cerebral vasospasm. Neurol Res (1984) 0.82
Subarachnoid hemorrhage as a cause of an adaptive response in cerebral arteries. J Neurosurg (2000) 0.82
Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys. J Neurosurg (1995) 0.81
Cisternal washing therapy for the prevention of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl (2001) 0.81
Intrathecal nimodipine therapy in a primate model of chronic cerebral vasospasm. Neurosurgery (1988) 0.81
Effectiveness of the head-shaking method combined with cisternal irrigation with urokinase in preventing cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg (2004) 0.81
Intrathecal methods. Neurosurg Clin N Am (2004) 0.81
Reversal of cerebral arterial spasm by intrathecal administration of a calcium antagonist (nimodipine). Acta Neurochir (Wien) (1984) 0.79
Effect of endothelinA-receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm. J Cardiovasc Pharmacol (1993) 0.79
Preventive effect of intracisternal heparin for proliferative angiopathy after experimental subarachnoid haemorrhage in rats. Acta Neurochir (Wien) (1994) 0.79
Current treatment of leptomeningeal metastases: systemic chemotherapy, intrathecal chemotherapy and symptom management. Cancer Treat Res (2005) 0.79
Observations on the effects of intrathecal papaverine in experimental vasospasm. J Neurosurg (1973) 0.79
Inhibition of endothelin-converting enzyme activity in the rabbit basilar artery. Neurosurgery (2001) 0.79
Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) (1994) 0.78
Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm. Neurosurgery (1989) 0.78
Vasospasm in monkeys resolves because of loss of and encasement of subarachnoid blood clot. Stroke (2001) 0.77
[Continuous intrathecal administration of nicardipine using a portable infusion pump system for management of vasospasm after subarachnoid hemorrhage]. No Shinkei Geka (2001) 0.77
Intrathecal sodium nitroprusside improves cerebral blood flow and oxygenation in refractory cerebral vasospasm and ischemia in humans. Stroke (2000) 0.77
Fundamentals of interventional pain medicine. Neurologist (2005) 0.77
Pharmacokinetics of controlled-release polymers in the subarachnoid space after subarachnoid hemorrhage in rabbits. J Neurosurg (2004) 0.77
Antifibrinolytic therapy of subarachnoid hemorrhage by intrathecal administration of p-aminomethylbenzoic acid. J Neurol (1978) 0.76
Preventive nimodipine and acute aneurysm surgery. Heading for the control of complications after aneurysmal subarachnoid hemorrhage. Neurochirurgia (Stuttg) (1985) 0.76
The permeability change of major cerebral arteries in experimental vasospasm. Neurosurgery (1992) 0.76
Intrathecal treatment for spasticity. Stereotact Funct Neurosurg (2001) 0.76
Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol (2008) 8.79
Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet (2007) 8.68
von Hippel-Lindau disease. Lancet (2003) 6.20
Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med (2006) 6.17
An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med (2009) 4.97
Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA (2004) 4.82
Prevention of intraoperative cerebrospinal fluid leaks by lumbar cerebrospinal fluid drainage during surgery for pituitary macroadenomas. J Neurosurg (2012) 3.35
The emerging biology of the nitrite anion. Nat Chem Biol (2005) 2.88
Posterior subtemporal transtentorial approach to intraparenchymal lesions of the anteromedial region of the superior cerebellum. J Neurosurg (2005) 2.69
Pathophysiology of persistent syringomyelia after decompressive craniocervical surgery. Clinical article. J Neurosurg Spine (2010) 2.49
Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. JAMA (2005) 2.47
Nitrite infusion in humans and nonhuman primates: endocrine effects, pharmacokinetics, and tolerance formation. Circulation (2007) 2.46
The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg (2003) 2.34
Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood (2004) 2.27
Hypo-functional SLC26A4 variants associated with nonsyndromic hearing loss and enlargement of the vestibular aqueduct: genotype-phenotype correlation or coincidental polymorphisms? Hum Mutat (2009) 2.25
Neurofibromatosis type 2. Lancet (2009) 2.24
Retrospective analysis of a concurrent series of microscopic versus endoscopic transsphenoidal surgeries for Knosp Grades 0-2 nonfunctioning pituitary macroadenomas at a single institution. J Neurosurg (2014) 2.13
Pathophysiology of primary spinal syringomyelia. J Neurosurg Spine (2012) 1.92
Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion. J Neurosurg (2002) 1.79
Mechanisms of morbid hearing loss associated with tumors of the endolymphatic sac in von Hippel-Lindau disease. JAMA (2007) 1.73
Retracted Application and implementation of selective tissue microdissection and proteomic profiling in neurological disease. Neurosurgery (2009) 1.69
Real-time imaging of convection-enhanced delivery of viruses and virus-sized particles. J Neurosurg (2007) 1.68
Prospective evaluation of the characteristics and incidence of adenoma-associated dural invasion in Cushing disease. J Neurosurg (2011) 1.64
User-friendly software for the analysis of brain lesions (ABLe). Comput Methods Programs Biomed (2007) 1.63
Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease. J Neurosurg (2009) 1.61
Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors. J Neurosurg (2012) 1.59
Metastases to hemangioblastomas in von Hippel-Lindau disease. J Neurosurg (2006) 1.58
Long-term natural history of hemangioblastomas in patients with von Hippel-Lindau disease: implications for treatment. J Neurosurg (2006) 1.55
Intraoperative infrared functional imaging of human brain. Ann Neurol (2003) 1.54
von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells. PLoS Med (2007) 1.52
Quantification of brain lesions using interactive automated software. Behav Res Methods Instrum Comput (2002) 1.51
West Nile virus: pathogenesis and therapeutic options. Ann Intern Med (2004) 1.51
Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note. J Neurosurg (2007) 1.51
The vestibular aqueduct: site of origin of endolymphatic sac tumors. J Neurosurg (2008) 1.49
Convective distribution of macromolecules in the primate brain demonstrated using computerized tomography and magnetic resonance imaging. J Neurosurg (2003) 1.48
Normal vision despite narrowing of the optic canal in fibrous dysplasia. N Engl J Med (2002) 1.47
Spoiled gradient recalled acquisition in the steady state technique is superior to conventional postcontrast spin echo technique for magnetic resonance imaging detection of adrenocorticotropin-secreting pituitary tumors. J Clin Endocrinol Metab (2003) 1.44
Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease. AJNR Am J Neuroradiol (2003) 1.44
Clinically relevant complications related to pedicle screw placement in thoracolumbar surgery and their management: a literature review of 35,630 pedicle screws. Neurosurg Focus (2011) 1.43
Cochlear implantation for hearing loss associated with bilateral endolymphatic sac tumors in von Hippel-Lindau disease. Otol Neurotol (2007) 1.41
Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes. Arthritis Rheum (2012) 1.40
Call for uniform neuropsychological assessment after aneurysmal subarachnoid hemorrhage: Swiss recommendations. Acta Neurochir (Wien) (2015) 1.40
Tumors of the endolymphatic sac in von Hippel-Lindau disease. N Engl J Med (2004) 1.38
The history of pituitary surgery for Cushing disease. J Neurosurg (2011) 1.38
Single-trial fMRI shows contralesional activity linked to overt naming errors in chronic aphasic patients. J Cogn Neurosci (2010) 1.38
Developmental arrest of angioblastic lineage initiates tumorigenesis in von Hippel-Lindau disease. Cancer Res (2003) 1.38
Evaluation of essential tremor with multi-voxel magnetic resonance spectroscopy. Neurology (2003) 1.36
Clinical and molecular analysis of disseminated hemangioblastomatosis of the central nervous system in patients without von Hippel-Lindau disease. Report of four cases. J Neurosurg (2002) 1.35
Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropathol Exp Neurol (2002) 1.35
Cerebrovascular disease associated with sickle cell pulmonary hypertension. Am J Hematol (2006) 1.35
Hemangioblastomas share protein expression with embryonal hemangioblast progenitor cell. Cancer Res (2006) 1.34
Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model. Neoplasia (2007) 1.33
Surface properties, more than size, limiting convective distribution of virus-sized particles and viruses in the central nervous system. J Neurosurg (2005) 1.31
Successful treatment of melanoma brain metastases with adoptive cell therapy. Clin Cancer Res (2010) 1.31
Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats. J Neurosurg (2003) 1.30
Surgery versus watchful waiting in patients with craniofacial fibrous dysplasia--a meta-analysis. PLoS One (2011) 1.27
Cushing's syndrome during pregnancy: personal experience and review of the literature. J Clin Endocrinol Metab (2005) 1.24
Long-term outcome of optic nerve encasement and optic nerve decompression in patients with fibrous dysplasia: risk factors for blindness and safety of observation. Neurosurgery (2006) 1.23
Real-time, image-guided, convection-enhanced delivery of interleukin 13 bound to pseudomonas exotoxin. Clin Cancer Res (2006) 1.23
Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg (2003) 1.23
Edema is a precursor to central nervous system peritumoral cyst formation. Ann Neurol (2005) 1.23
Surgical management of brainstem hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg (2003) 1.21
Pathophysiology of headache associated with cough in patients with Chiari I malformation. J Neurosurg (2003) 1.20
Safety and feasibility of long-term intravenous sodium nitrite infusion in healthy volunteers. PLoS One (2011) 1.19
Protein patterns and proteins that identify subtypes of glioblastoma multiforme. Oncogene (2004) 1.18
Endolymphatic sac tumors in von Hippel-Lindau disease. J Neurosurg (2004) 1.17
Real-time in vivo imaging of the convective distribution of a low-molecular-weight tracer. J Neurosurg (2005) 1.17
N-CoR pathway targeting induces glioblastoma derived cancer stem cell differentiation. Cell Cycle (2007) 1.17
Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel-Lindau disease. Neuro Oncol (2009) 1.17
Effect of ependymal and pial surfaces on convection-enhanced delivery. J Neurosurg (2008) 1.17
Image-guided convection-enhanced delivery of gemcitabine to the brainstem. J Neurosurg (2007) 1.17
Cerebrovascular disease in HIV-infected pediatric patients: neuroimaging findings. AJR Am J Roentgenol (2002) 1.17
White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis. Brain (2011) 1.15
Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PLoS One (2012) 1.13
Tumors of the endolymphatic sac in patients with von Hippel-Lindau disease: implications for their natural history, diagnosis, and treatment. J Neurosurg (2005) 1.13
Optic neuropathy in McCune-Albright syndrome: effects of early diagnosis and treatment of growth hormone excess. J Clin Endocrinol Metab (2012) 1.13
Postoperative testing to predict recurrent Cushing disease in children. J Clin Endocrinol Metab (2009) 1.11
Convective delivery of glial cell line-derived neurotrophic factor in the human putamen. J Neurosurg (2007) 1.11
Effects of VHL deficiency on endolymphatic duct and sac. Cancer Res (2005) 1.11
Pituitary stalk hemangioblastomas in von Hippel-Lindau disease. J Neurosurg (2009) 1.10
Coexpression of erythropoietin and erythropoietin receptor in von Hippel-Lindau disease-associated renal cysts and renal cell carcinoma. Clin Cancer Res (2005) 1.09
A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma. Neuro Oncol (2011) 1.09
A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomas. Neuro Oncol (2010) 1.08
Convection perfusion of glucocerebrosidase for neuronopathic Gaucher's disease. Ann Neurol (2005) 1.08
Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg (2008) 1.06